p53-Mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 10, 2008, Pages 2110-2119

  Faniello, Maria Concetta ^a   Di Sanzo, Maddalena ^a   Quaresima, Barbara ^a   Baudi, Francesco ^a   Di Caro, Valentina ^b   Cuda, Giovanni ^a   Morrone, Giovanni ^a   Del Sal, Giannino ^c,d   Spinelli, Giovanni ^b   Venuta, Salvatore ^a   Costanzo, Francesco ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Laboratorio Nazionale Consorzio Interuniversitario Biotecnologie   (Italy)

^d Dipartimento di Biochimica Biofisica Chimica Delle Macromolecole   (Italy)

Author keywords

Ferritin gene; Transcriptional factor; Transcriptional regulation

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; FERRITIN; NUCLEAR FACTOR Y; PROTEIN P53; SMALL INTERFERING RNA;

ACETYLATION; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE CONTROL; GENETIC CODE; GENETIC TRANSCRIPTION; HEAVY CHAIN; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

APOFERRITINS; CCAAT-BINDING FACTOR; CHROMATIN IMMUNOPRECIPITATION; DOWN-REGULATION; DOXORUBICIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HELA CELLS; HUMANS; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 48949117520     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.02.010     Document Type: Article

References (49)

1. Arcari P., Martinelli R., and Salvatore F. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species. Nucleic Acids Res. 12 (1984) 9179-9189
2. Arosio P., Adelman T.G., and Drysdale J.W. On ferritin heterogeneity. J. Biol. Chem. 253 (1978) 4451-4458
3. Arosio P., and Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radical Biol. Med. 15 (2002) 457-463
4. Bellorini M., Lee D.K., Dantonel J.C., Zemzoumi K., Roeder R.G., Tora L., et al. CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acids Res. 25 (1997) 2174-2181
5. Bevilacqua M.A., Faniello M.C., Cimino F., and Costanzo F. Okadaic acid stimulates H ferritin transcription in HeLa cells by increasing the interaction between the p300 co-activator molecule and the transcription factor Bbf. Biochem. Biophys. Res. Commun. 240 (1997) 179-182
6. Bevilacqua M.A., Faniello M.C., D'Agostino P., Quaresima B., Tiano M.T., Pignata S., et al. Transcriptional activation of the H-ferritin gene in differentiated Caco-2 cells parallels a change in the activity of the nuclear factor Bbf. Biochem. J. 311 (1995) 769-773
7. Bevilacqua M.A., Faniello M.C., Iovine B., Russo T., Cimino F., and Costanzo F. Transcription factor NF-Y regulates differentiation of CaCo-2 cells. Arch. Biochem. Biophys. 407 (2002) 39-44
8. Bevilacqua M.A., Faniello M.C., Quaresima B., Tiano M.T., Giuliano P., Feliciello A., et al. A common mechanism underlying the E1A repression and the cAMP stimulation of the H ferritin transcription. J. Biol. Chem. 272 (1997) 20736-20741
9. Bevilacqua M.A., Faniello M.C., Russo T., Cimino F., and Costanzo F. Transcriptional regulation of the human H ferritin-encoding gene (FERH) in G418-treated cells: Role of the B-box-binding factor. Gene 141 (1994) 287-291
10. Bevilacqua M.A., Faniello M.C., Russo T., Cimino F., and Costanzo F. P/CAF/p300 complex binds the promoter for the heavy subunit of ferritin and contributes to its tissue-specific expression. Biochem. J. 335 (1998) 521-525
11. Bevilacqua M.A., Giordano M., D'Agostino P., Santoro C., Cimino F., and Costanzo F. Promoter for the human ferritin heavy chain-encoding gene (FERH): Structural and functional characterization. Gene 111 (1992) 255-260
12. Bolognese F., Wasner M., Dohna C.L., Gurtner A., Ronchi A., Muller H., et al. The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated. Oncogene 18 (1999) 1845-1853
13. Bomford A.B., and Munro H.N. Ferritin gene expression in health and malignancy. Pathobiology 60 (1992) 10-18
14. Ceribelli M., Alcalay M., Vigano M.A., and Mantovani R. Repression of new p53 targets revealed by ChIP on chip experiments. Cell Cycle 5 (2006) 1102-1110
15. Corna G., Galy B., Hentze M.W., and Cairo G. IRP1-independent alteration of cardiac iron metabolism in doxorubicin-treated mice. J. Mol. Med. 84 (2006) 551-560
16. Costanzo F., Castagnoli L., Dente L., Arcari P., Smith M., Costanzo P., et al. Cloning of several cDNA segments coding for human liver proteins. EMBO J. 2 (1983) 57-61
17. Cozzi A., Corsi B., Levi S., Santambrogio P., Albertini A., and Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: In vivo role of ferritin ferroxidase activity. J. Biol. Chem. 275 (2000) 25122-25129
18. Currie R.A. Biochemical characterization of the NF-Y transcription factor complex during B lymphocyte development. J. Biol. Chem. 273 (1998) 18220-18229
19. el-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., and Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet. 1 (1992) 45-49
20. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
21. Epsztejn S., Glickstein H., Picard V., Slotki I.N., Breuer W., Beaumont C., et al. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94 (1999) 3593-3603
22. Faniello M.C., Bevilacqua M.A., Condorelli G., de Crombrugghe B., Maity S.N., Avvedimento V.E., et al. The B subunit of the CAAT-binding factor NFY binds the central segment of the co-activator p300. J. Biol. Chem. 274 (1999) 7623-7626
23. Faniello M.C., Chirico G., Quaresima B., Cuda G., Allevato G., Bevilacqua M.A., et al. An alternative model of H ferritin promoter transactivation by c-Jun. Biochem. J. 363 (2002) 53-58
24. Gadea G., Lapasset L., Gauthier-Rouviere C., and Roux P. Regulation of Cdc42-mediated morphological effect: A novel function for p53. EMBO J. 21 (2002) 2373-2382
25. Ginsberg D., Mechta F., Yaniv M., and Oren M. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 9979-9983
26. Gostissa M., Morelli M., Mantovani F., Guida E., Piazza S., Collavin L., et al. The transcriptional repressor hDaxx potentiates p53-dependent apoptosis. J. Biol. Chem. 279 (2004) 48013-48023
27. Graham F.L., and van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52 (1973) 536-539
28. Imbriano C., Gurtner A., Cocchiarella F., Di Agostino S., Basile V., Gostissa M., et al. Direct p53 transcriptional repression: In vivo analysis of CCAAT containing G2/M promoters. Mol. Cell. Biol. 25 (2005) 3737-3751
29. Joshi A.A., Wu Z., Reed R.F., and Suttle D.P. Nuclear factor-Y binding to the topoisomerase IIα promoter is inhibited by both the p53 tumor suppressor and anticancer drugs. Mol. Pharmacol. 63 (2003) 359-367
30. Jung M.S., Yun J., Chae H.D., Kim J.M., Kim S.C., Choi T.S., et al. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene 20 (2001) 5818-5825
31. Kastan M.B., Zhan Q., el-Deiry W.S., Carrier F., Jacks T., Walsh W.V., et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71 (1992) 587-597
32. Klausner R.D., Rouault T.A., and Harford J.B. Regulating the fate of mRNA: The control of cellular iron metabolism. Cell 72 (1993) 19-28
33. Kubicka S., Kuhnel F., Zender L., Rudolph K.L., Plumpe J., Manns M., et al. p53 represses CAAT enhancer-binding protein (C/EBP)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesis. J. Biol. Chem. 274 (1999) 32137-32144
34. Levrero M., De Laurenzi V., Costanzo A., Gong J., Wang J.Y., and Melino G. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions. J. Cell Sci. 113 (2000) 1661-1670
35. Mack D.H., Vartikar J., Pipas J.M., and Laimins L.A. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363 (1993) 281-283
36. Maity S.N., Sinha S., Ruteshouser E.C., and de Crombrugghe B. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J. Biol. Chem. 267 (1992) 16574-16580
37. Manni I., Mazzaro G., Gurtner A., Mantovani R., Haugwitz U., Krause K., et al. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J. Biol. Chem. 276 (2001) 5570-5576
38. Marziali G., Perrotti E., Ilari R., Coccia E.M., Mantovani R., Testa U., et al. The activity of the CCAAT-box binding factor NF-Y is modulated through the regulated expression of its A subunit during monocyte to macrophage differentiation: Regulation of tissue-specific genes through a ubiquitous transcription factor. Blood 93 (1999) 519-526
39. Marziali G., Perrotti E., Ilari R., Testa U., Coccia E.M., and Battistini A. Transcriptional regulation of the ferritin heavy-chain gene: The activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Mol. Cell. Biol. 17 (1997) 1387-1395
40. Nakano K., and Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7 (2001) 683-694
41. Okamura S., Arakawa H., Tanaka T., Nakanishi H., Ng C.C., Taya Y., et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol. Cell 8 (2001) 85-94
42. Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., and Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362 (1993) 857-860
43. Pang J.H., and Chen K.Y. A specific CCAAT-binding protein, CBP/tk, may be involved in the regulation of thymidine kinase gene expression in human IMR-90 diploid fibroblasts during senescence. J. Biol. Chem. 268 (1993) 2909-2916
44. Seto E., Usheva A., Zambetti G.P., Momand J., Horikoshi N., Weinmann R., et al. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 12028-12032
45. Tacchini L., Recalcati S., Bernelli-Zazzera A., and Cairo G. Induction of ferritin synthesis in ischemic-reperfused rat liver: Analysis of the molecular mechanisms. Gastroenterology 113 (1997) 946-953
46. Torti F.M., and Torti S.V. Regulation of ferritin genes and protein. Blood 99 (2002) 3505-3516
47. Vousden K.H., and Lu X. Live or let die: The cell's response to p53. Nat. Rev. Cancer 2 (2002) 594-604
48. Yun J., Chae H.D., Choy H.E., Chung J., Yoo H.S., Han M.H., et al. p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J. Biol. Chem. 274 (1999) 29677-29682
49. Zhou Y., Mehta K.R., Choi A.P., Scolavino S., and Zhang X. DNA damage-induced inhibition of securin expression is mediated by p53. J. Biol. Chem. 278 (2003) 462-470